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Introduction. Sacrocolpopexy is a generally applied treatment for vault prolapse which can be performed laparoscopically or by
open laparotomy. Methods. Between October 2007 and December 2012, we performed a multicenter prospective cohort study
in 2 university and 4 teaching hospitals in the Netherlands. We included patients with symptomatic posthysterectomy vaginal
vault prolapse requiring surgical treatment, who either had abdominal or laparoscopic sacrocolpopexy. We studied surgery related
morbidity, which was divided in pre-, peri-, and postoperative characteristics. Results.We studied 85 patients, of whom 42 had open
abdominal and 43 laparoscopic sacrocolpopexy. In the laparoscopic sacrocolpopexy group, estimated blood loss was significantly
less compared to the abdominal group: 192mL (±126) versus 77mL (±182), respectively (𝑃 ≤ .001). Furthermore, hospital stay
was significantly shorter in the laparoscopic group (4.2 days) as compared to the abdominal group (2.4 days) (𝑃 ≤ .001). The
overall complication rate was not significantly different (𝑃 = .121). However there was a significant difference in favor of the
laparoscopic group in peri- and postoperative complications requiring complementary (conservative) treatment and/or extended
admittance (RR 0.24 (95%-CI 0.07–0.80), 𝑃 = .009). Conclusion. Laparoscopic sacrocolpopexy reduces blood loss and hospital stay
as compared to abdominal sacrocolpopexy and generates less procedure related morbidity.
1. Introduction
The incidence of posthysterectomy vault prolapse requiring
surgery has been estimated at 36 per 10,000 women years [1].
The risk increases cumulatively with years after hysterectomy
and increases significantly in women whose initial hysterec-
tomy was performed for genital prolapse [1–3]. In an aging
population, the number of women that will seekmedical help
for a vaginal vault prolapse will increase due to an improved
life expectancy and due to the aging population.
Surgery for pelvic organ prolapse, including vaginal vault
prolapse, focuses on the restoration of the normal vaginal
anatomy and normal bladder and bowel function. To date,
a variety of different surgical procedures to correct vaginal
vault prolapse have been reported [4]. These reconstructive
techniques can principally be divided into vaginal or abdom-
inal procedures. The abdominal approach can be performed
open or laparoscopically. According to a Cochrane review
on the subject, abdominal sacrocolpopexy is associated with
a lower rate of recurrent vault prolapse compared to the
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vaginal sacrospinous fixation [5]. Success rates of abdominal
sacrocolpopexy range between 93% and 99% [6, 7].
The first report of a laparoscopic approach for sacro-
colpopexy was written in 1994 [8]. Laparoscopy has potential
advantages in terms of reduced morbidity, shorter hospital
stay, and convalescence. Surgically, it has been suggested that
there is easier access and placement of the mesh down the
posterior vaginal wall comparedwith the open procedure [9].
Previous studies showed less blood loss and a significantly
shorter hospital stay in the laparoscopic group [5, 9, 10].These
studies show no significant difference in complication rate;
however in the abdominal group more severe complications
occurred [9].
All previous studies have shown less morbidity in favor
of the laparoscopic method, but prospective comparisons
are lacking, specifically to evaluate differences in compli-
cation rates between both procedures. We performed a
prospective cohort study to compare complication rates of
the open abdominal sacrocolpopexy and the laparoscopic
sacrocolpopexy.
2. Materials and Methods
We report on patients who underwent surgery for posthys-
terectomy symptomatic vault prolapse between 2007 and
2012. The study was performed in 4 teaching and 2 academic
hospitals in the Netherlands. The study was approved by the
ethical committees of all participating hospitals.
The patient population consisted of women with a his-
tory of hysterectomy followed by a symptomatic vault pro-
lapse requiring surgical treatment. Patients having a contra-
indication for sacrocolpopexy were excluded. Women who
had undergone previous abdominal or vaginal vault prolapse
surgery were also excluded.
The population of this study exists of prospectively
enrolled patients who were eligible for both surgical tech-
niques (laparoscopy and open sacrocolpopexy) at time of
inclusion. Part of the patients were placed in a group depen-
dent on their own preference. Other patients participated in
randomized clinical trial comparing laparoscopy and open
surgery (ISRCT number: NTR3276) which is still enrolling,
and were therefore allocated by blind randomization. This
randomized trial is not the focus of the current report.
All patients gave permission to use their medical data after
signing written informed consent. Women received a case
number to treat their data anonymously.
2.1. Surgical Intervention. Interventions were either abdom-
inal or laparoscopic sacrocolpopexy. Patients received bowel
preparation the day before the operation. Prophylactic antibi-
otics were given preoperatively, for example, metronida-
zole/cefazolin. As prophylaxis for thromboembolism pre-
and postoperatively subcutaneous daltaparine was adminis-
tered.
Looking at the design of this surgical intervention, the
main goal of sacrocolpopexy is to reconstitute an adequate,
safe, safe durable system of support and suspension vagina by
replacing the impaired and/or detached native fascial tissue
with a synthetic nonabsorbable prosthesis.
2.2. Abdominal Sacrocolpopexy. Theabdominal sacrocolpop-
exy was performed by a laparotomy under general anesthesia.
A Pfannenstiel incisionwas used preferably. One piece of type
1 polypropylene mesh was attached anteriorly and another as
far down the posterior vaginal wall as possible. Both meshes
were sutured to each other afterwhich the posteriormeshwas
fixed to the sacrum. The mesh was peritonealised at several
points.
2.3. Laparoscopic Sacrocolpopexy. The laparoscopic sacro-
colpopexy was performed under general anesthesia with
four trocars, one for the scope and three side trocars.
The procedure was the same as the abdominal procedure.
The vaginal vault was elevated with a vaginal probe. The
peritoneumwas incised laparoscopically by scissors to expose
the rectovaginal and vesicovaginal fascia, extending to the
sacral promontory. One piece of type 1 polypropylene mesh
was attached anteriorly and another as far down the posterior
vaginal wall as possible. The mesh was attached to the sacral
promontory using staples. The mesh was peritonealised at
several points.
Both procedures were completed with any necessary
vaginal operation after the vault suspension had been carried
out. All centers used polypropylene meshes, the same sutures
(vicryl) to attach the mesh to the vaginal vault and staples for
attachment of the mesh to the sacrum. A urethral catheter
was left insitu and was removed after 24 hours postoperative
or as clinically indicated. Study surgeons were skilled in
performing one or both procedures. To exclude a learning
curve, they needed to have performed at least twenty-five
procedures prior to the start of participation of the study.
Data collection included duration of symptoms, body
mass index, pre- or postmenopausal status, use of estrogens,
combined prolapse surgery or stress urinary incontinence,
procedure time, amount of estimated blood loss and hospital
stay, and perioperative complications. Complications were
defined as unintended and undesirable events or situa-
tions during or because of a medical intervention, which
will have (temporary) negative effects on patients well-
being. Severe complications were defined as peri- and post-
operative complications due to the surgical intervention
requiring complementary (conservative) treatment and/or
extended admittance.TheDutch complication registration of
theNVOG (Dutch Society ofObstetrics andGynecology) [11]
was used to separate minor from major complications.
Preoperative, at 6 weeks, and 1 year postoperative a pelvic
examination was done according to the recommendations
of the ICS (POP-Q classification) to evaluate the anatomical
results of prolapse repair.
2.4. Statistical Analysis. Data were analyzed based on inten-
tion to treat principle. To examine differences between groups
we used an unpaired 𝑡-test for continuous variables and a chi-
square or, if opportune, Fisher’s exact test for dichotomous
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Median (IQR) 66.2 (61.2–72.7) 67.6 (64.1–73.6) .746
Body mass index (kg/m2)
Median (IQR) 25.4 (22.5–27.4) 25.6 (23.9–28.3) .805
Parity (n/m) .311
0 2.4% (1/42) 0.0% (0/40)
1 7.1% (3/42) 7.5% (3/40)
2 42.9% (18/42) 45.0% (18/40)
3 40.5% (17/42) 25.0% (10/40)
≥4 7.1% (3/42) 22.5% (9/40)
Menopausal status (n/m) .543
Premenopausal 2.3% (1/44) 4.7% (2/43)
Postmenopausal 97.7% (43/44) 95.3% (41/43)
Incontinence (n/m) .453
None 59.5% (25/42) 51.2% (21/41)
Stress 4.8% (2/42) 7.3% (3/41)
Urge 14.3% (6/42) 7.3% (3/41)
Combined 21.4% (9/42) 34.1% (14/41)
Estrogens use (n/m) .122
None 94.3% (33/35) 82.4% (28/34)
Local/Systemic 5.7% (2/35) 17.6% (6/34)
History of gynecological surgery (n/m) .143
TVH only 38.1% (16/42) 27.5% (11/40)
TVH and ACR 9.5% (4/42) 5.0% (2/40)
TVH and PCR 2.4% (1/42) 20.0% (8/40)
TVH and ACR/PCR 28.6% (12/42) 12.5% (5/40)
TVH, later ACR and mesh 2.4% (1/42) 0.0% (0/40)
TAH, ACR and later PCR 0.0% (0/42) 2.5% (1/40)
TAH only 9.5% (4/42) 27.5% (11/40)
TAH and PCR 2.4% (1/42) 2.5% (1/40)
Laparoscopic hysterectomy 4.8% (2/42) 0.0% (0/40)
Supracervical hysterectomy 2.4% (1/42) 0.0% (0/40)
TVH: transvaginal hysterectomy, TAH: total abdominal hysterectomy.
ACR: anterior colporrhaphy, PCR: posterior colporrhaphy.
variables. A𝑃 value of <0.05 was considered to be statistically
significant. The statistical package used was SPSS 20.0.
3. Results
Baseline Characteristics. We included 85 patients in our study,
of whom 42 had undergone open abdominal sacrocolpopexy
and 43 had undergone laparoscopic sacrocolpopexy. Pre-
and postoperative morbidity data could be analyzed in all
85 patients. Table 1 shows the baseline characteristics of the
studied population. No significant differences were observed
between both groups. Preoperative POP-Q was also not
different in both groups (Table 2).
Table 3 shows perioperative data. In the laparoscopic
sacrocolpopexy group estimated blood loss was significantly
less compared to the abdominal group: 192mL (±126) versus
77mL (±182), respectively (𝑃 ≤ .001). Furthermore, hospital
stay was significantly shorter in the laparoscopic group (4.2
days) as compared to the abdominal group (2.4 days) (𝑃 ≤
.001). Mean operation time in the abdominal group was
118min, whereas themean operation time in the laparoscopic
procedure was 128min (𝑃 = .254).
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Aa −0.3 ± 1.8(−3–3)
−0.5 ± 1.6
(−3–3) .667
Ba 0.6 ± 2.8(−5–8)
0.6 ± 2.3
(−3–4) .766
C −0.3 ± 4.2(−8–10)
1.0 ± 2.3
(−6–6) .092
GH 3.7 ± 0.8(3–5)
3.7 ± 0.8
(2–5) .361
PB 3.1 ± 0.5(2–4)
2.5 ± 0.9
(0–3) .102
TVL 7.9 ± 1.5(4–10)
7.7 ± 1.3
(6–11) .374
Ap −0.7 ± 1.7(−3–3)
−1.2 ± 1.9
(−3–3) .142
Bp 0.1 ± 2.7(−4–8)
−0.4 ± 2.5
(−3–4) .444
D — — —









Median (IQR) 120 (110–140) 120 (105–132) .884
Estimated blood loss (mL)
Median (IQR) 50 (10–100) 200 (100–250) <.001
Hospital stay (days)
Median (IQR) 2 (2-3) 4 (3–5) <.001
In the laparoscopic group 8 (18.6%) patients had one
or more complications compared to 14 (33.3%) patients in
the abdominal group which was not significantly different
(RR 0.558 (95%-CI 0.26–1.19), 𝑃 = .121). We divided
complications in peri- and postoperative complications.
Perioperative complications are listed in Table 4. There
were 5 (11.6%) complications in the laparoscopic group,
versus 3 (7.1%) in the open abdominal group (𝑃 = .489).
In the laparoscopic group in one case the procedure had to
be converted to an open abdominal sacrocolpopexy due to a
bleeding coming from the promontory.This bleeding resulted
in a total estimated blood loss of 1200mL. This patient
also developed an abdominal wall hematoma around the
median laparotomy scar. In another patient a bleeding of the
right ovarian artery occurred while fixating the mesh to the
promontory. The total estimated blood loss in this case was
200mL. In the laparoscopic group 2 bladder injuries occurred
of which in one case the operation had to be converted to a
vaginal procedure. In one patient in the laparoscopic group
the mesh had to be fixated to the ventral abdominal wall
because of poor visualization and excessive vascularization of
the promontory.
In the open abdominal group one procedure had to be
converted to intravaginal slingplasty due to severe adhesions.
In one patient in the open abdominal group some of themesh
sutures were put through the bladder, detected and cut by
cystoscopy. One other patient had a bladder injury which was
repaired directly.
Postoperative complications are also listed in Table 4.
Most of the complications were found in the open abdominal
group.Therewere 6 (14.0%) complications in the laparoscopic
group, versus 13 (31.0%) in the open abdominal group (𝑃 =
.086). In the laparoscopic group there was one patient with
atrial fibrillation and another patient had symptoms of angina
pectoris; nevertheless in both cases no cardiac ischemia
could be diagnosed. There was one postoperative wound
infection of the umbilical trocar incision and an abdominal
wall hematoma; however no complementary treatment was
needed.
In the abdominal group one patient died postoperatively
because of multiorgan failure due to a sepsis after a bowel
Obstetrics and Gynecology International 5









One or more complications 11.1% (5) 7.1% (3)
Severe adhesions — 2.4% (1)
Bladder lesion 4.7% (2) 4.8% (2)
Bleeding 4.7% (2) —
Alternative mesh fixation 2.3% (1) —
Postoperative complications .086
One or more complications 14.0% (6) 28.6% (12)
Fatal bowel perforation — 2.4% (1)
Wound dehiscence — 4.8% (2)
Pulmonary embolism — 2.4% (1)
Ileus — 7.1% (3)
Abdominal wall hematoma 2.3% (1) 4.8% (2)
Cardiac complication 4.7% (2) —
Delirium — 2.4% (1)
Wound infection 2.3% (1) —
Urinary tract infection — 2.4% (1)
Urinary retention 4.7% (2) 4.8% (2)
One or more treated complications∗ 7.0% (3) 28.6% (12) .009
One or more major complications∗∗ — 7.1% (3) .074
∗Complications due to the surgical intervention requiring complementary (conservative) treatment and/or extended admittance.
∗∗According to the Dutch complication registration of the NVOG [11].
perforation. She had a relaparotomy but developed a pneu-
monia postoperatively and in combination with multiorgan
failure and cardiac arrhythmia, this resulted in a fatal com-
plication 5 days postoperative. Two patients had a wound
dehiscence which needed to be surgically repaired. One
patient developed a pulmonary embolism which required
therapeutic anticoagulant therapy. In three patients, which
were 7.1% of the patients in the open abdominal group, an
ileus was diagnosed. These three patients recovered after
conservative treatment. In two patients there was an abdom-
inal hematoma; however no complementary treatment was
needed. One patient had temporary a mild delirium during
admittance. Another patient had symptoms of dysuria in
combination with fever caused by an urinary tract infection
and was treated with antibiotics. Postoperatively, we found
two patients in each group with urinary retention.
Three (7.0%) patients in the laparoscopic group and 12
(28.6%) patients in the abdominal group had peri- and
postoperative complications due to the surgical intervention
requiring complementary (conservative) treatment and/or
extended admittance which was significantly different (RR
0.24 (95%-CI 0.07–0.80), 𝑃 = .009). When we separated
the minor peri- and postoperative complications from the
major complications according to the Dutch complication
registration of the NVOG (Dutch Society of Obstetrics and
Gynecology) [11], there were no major complications in
the laparoscopic group and 3 (7.1%) major complications in
the abdominal group which is not statistically significant
(𝑃 = .074). Two of these three major complications of the
abdominal group are classified as category B because a re-
operation was required to repair the wound dehiscence. The
third complication was a category D complication since the
complication was fatal [11].
Six weeks postoperative there were 16 (18.8%) complica-
tions seen which are shown in Table 5. There were 7 (16.7%)
complications in the laparoscopic group, versus 9 (21.4%) in
the open abdominal group (𝑃 = .527). In the laparoscopic
group seven patients had complications of which five patients
(11.6%) had constipation, one patient (2.3%) developed de
novo stress urinary incontinence, and another patient (2.3%)
had de novo urge incontinence. The complications of the
open abdominal sacrocolpopexy group consisted of three
patients (7.1%) with de novo stress urinary incontinence,
three patients (7.1%) had symptoms of constipation, another
two patients (4.8%) had recurrent urinary tract infections
and one patient (2.4%) had bothersome pain around the
Pfannenstiel incision. Because all these complications could
be a result of permanent loss of function, they are classified
as category C complications according to the Dutch compli-
cation registration of the NVOG [11].
6 Obstetrics and Gynecology International








Complications 6 weeks postoperative .527
One or more complications 16.7% (7) 21.4% (9)
Constipation 11.6% (5) 7.1% (3)
De novo stress incontinence 2.3% (1) 7.1% (3)
De novo urinary incontinence 2.3% (1) —
Recurrent urinary tract infections — 4.8% (2)
Bothersome pain around incision — 2.4% (1)
4. Discussion
We performed a prospective cohort study with 85 patients
who underwent a sacrocolpopexy either abdominally or
laparoscopically for vaginal vault prolapse.Morbidity was less
in the laparoscopic group. Less blood loss during surgery
and a shorter hospital stay were seen in the laparoscopic
sacrocolpopexy group. The overall complication rate was not
significant different in both groups; however a trend was seen
towards less complications in the laparoscopic group. Peri-
and postoperative complications, due to the surgical inter-
vention requiring complementary (conservative) treatment
and/or extended admittance, was significantly different in
favor of the laparoscopic group. No significant difference was
seen in operation time.
Both the Cochrane collaboration and the National Insti-
tute for Clinical Excellence (NICE, UK) have recommended
abdominal sacrocolpopexy with mesh as the optimal surgical
treatment for vaginal vault prolapse [12, 13]. Both open and
laparoscopic procedures appear equally effective in several
case series [10, 14–17].
No large studies powered on complications rates of
sacrocolpopexy have been done. On the other hand, many
studies were done comparing open abdominal hysterectomy
to laparoscopic hysterectomy performed for benign diseases.
Two large trials of Garry et al. [18] and Maresh et al.
[19] showed a significantly higher complication rate in the
laparoscopic hysterectomy group. Nevertheless, hospital stay
and postoperative pain were less in the laparoscopic group.
We found less (severe) complications in the laparoscopic
sacrocolpopexy group. Our study showed similar results
on morbidity in accordance to previous studies comparing
open abdominal to laparoscopic sacrocolpopexy [5, 9, 10].
A randomized trial comparing laparoscopic to abdominal
sacrocolpopexy performed by Freeman et al. [9] showed
significantly less blood loss (56 versus 240mL), less mean
Hb drop (1.12 versus 2.33mg/dL), shorter hospital stay (3.2
versus 4.1 days), and less morphine use (16 versus 32mL) in
the laparoscopic group.There was no significant difference in
complication rate, but in the abdominal group more severe
complications occurred [9]. Our trial also showed more
severe complications in the abdominal group. The overall
complication rate of our study was not significantly different
(𝑃 = .121). However there was a significant difference in
perioperative complications due to the surgical intervention
requiring complementary (conservative) treatment and/or
extended admittance in favor of the laparoscopic group (𝑃 =
.009).
Nonrandomized cohort studies of Paraiso et al. [5] and
Klauschie et al. [10] also showed less blood loss and a
significantly shorter hospital stay in the laparoscopic group
[5, 10]. There was no difference in complication rate between
both studies [5, 10].
The complication rate of the laparoscopic group was
18.6% (8 patients) compared to a complication rate of 33.3%
(14 patients) in the abdominal group. In the abdominal group
3 patients (7.1%) of the patients were diagnosed with an ileus
postoperative. At six weeks postoperative 5 patients (11.6%)
of the laparoscopic group developed defecation problems
compared to 3 patients (7.1%) in the abdominal group. In
the abdominal group 3 patients (7.1%) developed de novo
stress incontinence. Bowel symptoms are also reported in
other studies comparing laparoscopic to abdominal sacro-
colpopexy [5, 9, 10]. Klauschie et al. [10] described one
severe bowel obstruction in the abdominal group. In the
study of Paraiso et al. [5] two patients developed an ileus
in the abdominal group, small bowel obstructions occurred
once in the laparoscopic group and twice in the abdominal
group and one patient of the laparoscopic group, had severe
constipation postoperatively. Freeman et al. [9] showed de
novo urinary incontinence in both groups, mainly in the
abdominal group (2 versus 4 patients) [9] which matches to
our study results. In contrast with other studies comparing
laparoscopic to abdominal sacrocolpopexy [5, 9, 10], nomesh
erosion has been seen in our study population. Patients
should be informed preoperatively about complications that
occur in more than 5%. This means that constipation and
urinary incontinence should be added to the counseling
prior to a sacrocolpopexy. For the abdominal sacrocolpopexy
counseling should also include the risk of ileus. Physicians
should screen patients at risk for bowel symptoms and
anticipate by prescribing prophylactic laxatives to prevent
constipation.
The complication rate in our study is higher than
prescribed in other studies comparing open abdominal to
laparoscopic sacrocolpopexy. Differences in complications
rates can be explained by our accurate complication regis-
tration. All minor and major complications were precisely
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documented resulting in honest prospective data. In contrast
with other studies all complications are mentioned and
prescribed, even when the complication was temporary and
did not affect the operation, time of admission, or treatment.
The study of Paraiso et al. [5] and Freeman et al. [9] prescribes
only severe or permanent complications.
This study has a few limitations. Some patients were
randomized as part of a larger trial that is not the focus of the
current report. Not all included patients were randomized.
We added a prospective cohort group of women with a
history of hysterectomy followed by a symptomatic vault
prolapse requiring surgical treatment. Only patients who
were eligible for both surgical options were asked for our
prospective cohort group. However we did not expect study
bias by including this prospective group to our randomized
group because we focused on procedure-related morbidity.
Patient’s or physician’s preference does not affect procedure
morbidity. Furthermore, no significant differences in baseline
characteristics were found.
Several studies showed that laparoscopic sacrocolpopexy
is attended with less morbidity and less severe complications
[5, 9, 10]. Our results also showed severe complications in the
open abdominal group, including a fatal bowel perforation.
5. Conclusions
Laparoscopic sacrocolpopexy seems to be related to less
procedure-related morbidity compared to open abdominal
sacrocolpopexy concerning less estimated blood loss, hospi-
tal, and severe complications. Laparoscopic sacrocolpopexy
is a safer treatment for vaginal vault prolapse compared to
abdominal sacrocolpopexy whereas this technique does not
prolong the operation.
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